Scientists map how transitions from day to night control gene regulatory networks in cyanobacteria, revealing key orchestrators of metabolic switching.

Scientists uncover how cyanobacteria's circadian cycle controls carbon and energy metabolism, increasing carbon dioxide-to-bioproducts yields.

PNNL scientists use proteomics to unveil how high-density lipoproteins protect against cholesterol accumulation in the artery wall.

Computing and artificial intelligence aid scientists who seek to understand function-driven design and control of biological systems.

PNNL researchers co-organized a workshop on fusion commercialization with partners from industry and academia

PNNL researchers will pursue both fundamental and applied projects with this support from the Department of Energy

Combining cold spray deposition and friction stir processing for a more efficient route to oxide dispersion strengthened steel.

PNNL researchers studied the microstructure of lithium silicates under emulated fusion conditions.

Researchers studied the boundary precipitation of tungsten heavy alloys in an extended high temperature irradiation environment

A new approach validates quantum algorithms for low-energy nuclear physics applications

The Department of Energy Office of Nuclear Energy acting assistant secretary makes his first visit to a national laboratory in his new role, touring PNNL's Radiochemical Processing Laboratory.

New apps help researchers with statistical analyses of data.

The new PTM-Psi workflow opens the door for uncovering molecular insights within proteomics datasets.

Researchers designed ultra-low radiation cables to reduce background noise for highly sensitive neutrino and dark matter detectors.

A team of researchers from PNNL provided technical knowledge and support to test a suite of techniques that detect genetically modified bacteria, viruses, and cells.

PNNL’s Richard Saldanha will lead a new project to benchmark and validate models of cosmic ray exposure

Scientists developed a process (or pipeline) that combined molecular probes—a specific chemical that binds to microbes carrying out a particular function—with a method that isolated these cells from their complex community.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.